These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
139 related articles for article (PubMed ID: 2764537)
1. Comparison of N-methylthiotetrazole dispositions in healthy volunteers following single intravenous doses of moxalactam, cefoperazone, and cefotetan. Welage LS; Hejmanowski LG; Wilton JH; Walawander C; Rigan D; Williams JS; Schentag JJ Antimicrob Agents Chemother; 1989 Jun; 33(6):857-61. PubMed ID: 2764537 [TBL] [Abstract][Full Text] [Related]
2. Comparative evaluation of the pharmacokinetics of N-methylthiotetrazole following administration of cefoperazone, cefotetan, and cefmetazole. Welage LS; Borin MT; Wilton JH; Hejmanowski LG; Wels PB; Schentag JJ Antimicrob Agents Chemother; 1990 Dec; 34(12):2369-74. PubMed ID: 2088192 [TBL] [Abstract][Full Text] [Related]
3. Kinetics and action of N-methylthiotetrazole in volunteers and patients. Population-based clinical comparisons of antibiotics with and without this moiety. Schentag JJ; Welage LS; Williams JS; Wilton JH; Adelman MH; Rigan D; Grasela TH Am J Surg; 1988 May; 155(5A):40-4. PubMed ID: 3163900 [TBL] [Abstract][Full Text] [Related]
5. Disposition of moxalactam and N-methyltetrazolethiol in rats and monkeys. Mizojiri K; Norikura R; Takashima A; Tanaka H; Yoshimori T; Inazawa K; Yukawa T; Okabe H; Sugeno K Antimicrob Agents Chemother; 1987 Aug; 31(8):1169-76. PubMed ID: 3631941 [TBL] [Abstract][Full Text] [Related]
6. The Association Between Cephalosporin and Hypoprothrombinemia: A Systematic Review and Meta-Analysis. Park GH; Kim S; Kim MS; Yu YM; Kim GH; Lee JS; Lee E Int J Environ Res Public Health; 2019 Oct; 16(20):. PubMed ID: 31623191 [TBL] [Abstract][Full Text] [Related]
7. [Hemostasis disturbance caused by cephalosporins with an N-methylthiotetrazole side chain. A randomized pilot study]. Schäfer H; Naber K; Adam D Arzneimittelforschung; 1989 Sep; 39(9):1156-62. PubMed ID: 2590268 [TBL] [Abstract][Full Text] [Related]
8. Inhibition of the rate of 14CO2 production from [14C]ethanol in rats given beta-lactam antibiotics with disulfiram-like effects. Turcan RG; MacDonald CM; Ings RM; Coombes JD Antimicrob Agents Chemother; 1985 Apr; 27(4):535-40. PubMed ID: 3923923 [TBL] [Abstract][Full Text] [Related]
9. Pharmacokinetics of latamoxef and N-methyltetrazolethiol in rats associated with the development of disulfiram-like effects. Matsubara T; Otsubo S; Ogawa A; Oka T Jpn J Pharmacol; 1987 Oct; 45(2):223-32. PubMed ID: 3437591 [TBL] [Abstract][Full Text] [Related]
10. Penetration and clearance of cefoperazone and moxalactam in pleural fluid. Yamada H; Iwanaga T; Nakanishi H; Yamaguchi M; Iida K Antimicrob Agents Chemother; 1985 Jan; 27(1):93-5. PubMed ID: 3985598 [TBL] [Abstract][Full Text] [Related]
11. Antimicrobial activity, beta-lactamase stability and beta-lactamase inhibition of cefotetan and other 7-alpha-methoxy beta-lactam antimicrobials. Jones RN; Wilson HW Diagn Microbiol Infect Dis; 1983 Mar; 1(1):71-83. PubMed ID: 6323095 [TBL] [Abstract][Full Text] [Related]
12. Comparative pharmacokinetics of moxalactam, cefoperazone, and cefotaxime in normal volunteers. Standiford HC; Drusano GL; McNamee WB; Tatem B; Ryan PA; Schimpff SC Rev Infect Dis; 1982; 4 Suppl():S585-94. PubMed ID: 6296967 [TBL] [Abstract][Full Text] [Related]
13. Hypoprothrombinemia and hemorrhage in a surgical patient treated with cefotetan. Kaiser CW; McAuliffe JD; Barth RJ; Lynch JA Arch Surg; 1991 Apr; 126(4):524-5. PubMed ID: 1901205 [TBL] [Abstract][Full Text] [Related]
14. Comparative pharmacokinetics of cefoperazone, cefotaxime, and moxalactam. Kemmerich B; Lode H; Belmega G; Jendroschek T; Borner K; Koeppe P Antimicrob Agents Chemother; 1983 Mar; 23(3):429-34. PubMed ID: 6303213 [TBL] [Abstract][Full Text] [Related]
15. Comparative pharmacokinetic analysis of latamoxef and CPW 86-363, a novel carboxy-pyrazol-cephalosporin and formation of N-methyl-thiotetrazole. Ganzinger U; Schatz F; Haberl H; Haslberger A; Schiel H; Hitzenberger G Int J Clin Pharmacol Ther Toxicol; 1987 Mar; 25(3):152-6. PubMed ID: 3557743 [TBL] [Abstract][Full Text] [Related]
16. Biliary excretion of latamoxef and N-methyltetrazolethiol in humans and rats. Uchida K; Konishi M; Akiyoshi T; Igimi H; Asakawa S J Pharmacobiodyn; 1985 Nov; 8(11):981-8. PubMed ID: 4093852 [TBL] [Abstract][Full Text] [Related]
17. Assessment of serum bactericidal activity after administration of cefoperazone, cefotaxime, ceftizoxime, and moxalactam to healthy subjects. Barriere SL; Ozasa DC; Mordenti J Antimicrob Agents Chemother; 1985 Jul; 28(1):55-7. PubMed ID: 3929680 [TBL] [Abstract][Full Text] [Related]
18. Diffusibility of the newer cephalosporins into human interstitial fluids. Tan JS; Salstrom SJ; File TM Am J Med; 1984 Oct; 77(4C):33-6. PubMed ID: 6093516 [TBL] [Abstract][Full Text] [Related]
19. The effects of 1-methyl-5-thiotetrazole in a rat liver vitamin K-dependent carboxylase assay. Smith GF; Sundboom JL Thromb Res; 1984 Mar; 33(6):633-44. PubMed ID: 6719405 [TBL] [Abstract][Full Text] [Related]
20. Mechanism of cephalosporin-induced hypoprothrombinemia: relation to cephalosporin side chain, vitamin K metabolism, and vitamin K status. Shearer MJ; Bechtold H; Andrassy K; Koderisch J; McCarthy PT; Trenk D; Jähnchen E; Ritz E J Clin Pharmacol; 1988 Jan; 28(1):88-95. PubMed ID: 3350995 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]